{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:58:22Z","timestamp":1787021902441,"version":"build-2736575974"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T00:00:00Z","timestamp":1381449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0075591","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T23:14:10Z","timestamp":1381533250000},"page":"e75591","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Deferred Pre-Emptive Switch from Calcineurin Inhibitor to Sirolimus Leads to Improvement in GFR and Expansion of T Regulatory Cell Population: A Randomized, Controlled Trial"],"prefix":"10.1371","volume":"8","author":[{"given":"Dinesh","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok K.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukut","family":"Minz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Sakhuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivekanand","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,10,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJM198605083141904","article-title":"A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years","volume":"314","year":"1986","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"BJ Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/sj.ki.5002154","article-title":"The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich","volume":"71","author":"CD Wimmer","year":"2007","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00007890-199803150-00010","article-title":"Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy","volume":"65","author":"G Mourad","year":"1998","journal-title":"Transplantation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000079390","article-title":"Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function","volume":"24","author":"MR Weir","year":"2004","journal-title":"Am J Nephrol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1600-6143.2004.00624.x","article-title":"Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival","volume":"4","author":"HU Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/j.1600-6143.2007.01976.x","article-title":"Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids","volume":"7","author":"M Buchler","year":"2007","journal-title":"Am J Transplant"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"H Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1600-6143.2005.01177.x","article-title":"Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus","volume":"6","author":"TS Larson","year":"2006","journal-title":"Am J Transplant"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1034\/j.1600-6143.2003.00185.x","article-title":"Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation","volume":"3","author":"JF Valente","year":"2003","journal-title":"Am J Transplant"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"FP Schena","year":"2009","journal-title":"Transplantation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(10)62318-5","article-title":"Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial","volume":"377","author":"K Budde","year":"2011","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1600-6143.2012.03994.x","article-title":"Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study","volume":"12","author":"K Budde","year":"2012","journal-title":"Am J Transplant"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/TP.0b013e3181e11798","article-title":"Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial","volume":"90","author":"M Guba","year":"2010","journal-title":"Transplantation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1432-2277.2012.01432.x","article-title":"Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation","volume":"25","author":"M Guba","year":"2012","journal-title":"Transpl Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1600-6143.2011.03637.x","article-title":"Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study","volume":"11","author":"Y Lebranchu","year":"2011","journal-title":"Am J Transplant"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1600-6143.2009.02615.x","article-title":"Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study","volume":"9","author":"Y Lebranchu","year":"2009","journal-title":"Am J Transplant"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ki.2010.492","article-title":"Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial","volume":"79","author":"MR Weir","year":"2011","journal-title":"Kidney Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1600-6143.2007.01829.x","article-title":"CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects","volume":"7","author":"SM Kang","year":"2007","journal-title":"Am J Transplant"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ki.2010.533","article-title":"Donor antigen-specific regulatory T-cell function affects outcome in kidney transplant recipients","volume":"79","author":"I Tsaur","year":"2011","journal-title":"Kidney Int"},{"key":"ref21","first-page":"942","article-title":"CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(\u2212) naive T cells display more potent regulatory ability in vitro","volume":"123","author":"JF Chen","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1600-6143.2007.01842.x","article-title":"Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells","volume":"7","author":"W Gao","year":"2007","journal-title":"Am J Transplant"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.tp.0000229473.95202.50","article-title":"Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients","volume":"82","author":"DS Segundo","year":"2006","journal-title":"Transplantation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/j.transproceed.2007.09.015","article-title":"The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation","volume":"39","author":"G Korczak-Kowalska","year":"2007","journal-title":"Transplant Proc"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/ndt\/gfs474","article-title":"Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype","volume":"28","author":"RP Carroll","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1600-6143.2007.02134.x","article-title":"CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H","volume":"8","author":"DD Bloom","year":"2008","journal-title":"Am J Transplant"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1681\/ASN.2006101143","article-title":"Regulatory T cells and T cell depletion: role of immunosuppressive drugs","volume":"18","author":"M Noris","year":"2007","journal-title":"J Am Soc Nephrol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0075591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T03:03:56Z","timestamp":1540004636000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0075591"}},"subtitle":[],"editor":[{"given":"Michael","family":"Zimmerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,11]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0075591","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,11]]}}}